Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance

BACKGROUND: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment costs. Traditional cost-effectiveness studies rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnani, Christopher J., Bievre, Nicolas, Baker, Laurence C., Brooks, James D., Blayney, Douglas W., Hernandez-Boussard, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751921/
https://www.ncbi.nlm.nih.gov/pubmed/33367287
http://dx.doi.org/10.1016/j.euros.2020.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751921/
https://www.ncbi.nlm.nih.gov/pubmed/33367287
http://dx.doi.org/10.1016/j.euros.2020.11.004

Ejemplares similares